1	Alpha-melanocyte-stimulating	Alpha-melanocyte-stimulating	B-NP	JJ	O	2	NMOD	-1
2	hormone	hormone	I-NP	NN	O	3	SUB	-1
3	modulates	modulate	B-VP	VBZ	O	0	ROOT	16	modulates
4	activation	activation	B-NP	NN	O	11	NMOD	17	activation
5	of	of	B-PP	IN	O	4	NMOD	-1
6	NF-kappa	NF-kappa	B-NP	NN	B-protein	7	NMOD	-1
7	B	B	I-NP	NN	I-protein	9	NMOD	-1
8	and	and	O	CC	O	9	NMOD	-1
9	AP-1	AP-1	B-NP	NN	B-protein	5	PMOD	-1
10	and	and	O	CC	O	11	NMOD	-1
11	secretion	secretion	B-NP	NN	O	3	OBJ	14	secretion
12	of	of	B-PP	IN	O	11	NMOD	-1
13	interleukin-8	interleukin-8	B-NP	NN	B-protein	12	PMOD	-1
14	in	in	B-PP	IN	O	11	NMOD	-1
15	human	human	B-NP	JJ	B-cell_type	17	NMOD	-1
16	dermal	dermal	I-NP	JJ	I-cell_type	17	NMOD	-1
17	fibroblasts	fibroblast	I-NP	NNS	I-cell_type	14	PMOD	-1
18	.	.	O	.	O	3	P	-1

1	Alpha-melanocyte-stimulating	Alpha-melanocyte-stimulating	B-NP	JJ	O	2	NMOD	-1
2	hormone	hormone	I-NP	NN	O	6	SUB	-1
3	(	(	O	(	O	5	DEP	-1
4	alpha-MSH	alpha-MSH	B-NP	NN	O	5	DEP	-1
5	)	)	O	)	O	2	NMOD	-1
6	has	have	B-VP	VBZ	O	0	ROOT	-1
7	evolved	evolve	I-VP	VBN	O	6	VC	-1
8	as	as	B-PP	IN	O	7	VMOD	-1
9	a	a	B-NP	DT	O	10	NMOD	-1
10	mediator	mediator	I-NP	NN	O	8	PMOD	16	mediator
11	of	of	B-PP	IN	O	10	NMOD	-1
12	diverse	diverse	B-NP	JJ	O	14	NMOD	-1
13	biological	biological	I-NP	JJ	O	14	NMOD	-1
14	activities	activity	I-NP	NNS	O	11	PMOD	0
15	in	in	B-PP	IN	O	10	NMOD	-1
16	an	an	B-NP	DT	O	18	NMOD	-1
17	ever-growing	ever-growing	I-NP	JJ	O	18	NMOD	1	growing
18	number	number	I-NP	NN	O	15	PMOD	-1
19	of	of	B-PP	IN	O	18	NMOD	-1
20	non-melanocytic	non-melanocytic	B-NP	JJ	B-cell_type	22	NMOD	-1
21	cell	cell	I-NP	NN	I-cell_type	22	NMOD	-1
22	types	type	I-NP	NNS	I-cell_type	19	PMOD	-1
23	.	.	O	.	O	6	P	-1

1	One	One	B-NP	CD	O	2	NMOD	-1
2	mechanism	mechanism	I-NP	NN	O	9	SUB	0
3	by	by	B-PP	IN	O	2	NMOD	-1
4	which	which	B-NP	WDT	O	3	PMOD	-1
5	alpha-MSH	alpha-MSH	B-NP	NN	B-protein	6	SUB	-1
6	exerts	exert	B-VP	VBZ	O	3	SBAR	-1
7	its	its	B-NP	PRP$	O	8	NMOD	-1
8	effects	effect	I-NP	NNS	O	6	OBJ	0
9	is	be	B-VP	VBZ	O	0	ROOT	-1
10	modulation	modulation	B-NP	NN	O	9	PRD	16	modulation
11	of	of	B-PP	IN	O	10	NMOD	-1
12	AP-1	AP-1	B-NP	NN	B-protein	15	NMOD	-1
13	and	and	O	CC	O	15	NMOD	-1
14	NF-kappa	NF-kappa	B-NP	NN	B-protein	15	NMOD	-1
15	B	B	I-NP	NN	I-protein	11	PMOD	-1
16	.	.	O	.	O	9	P	-1

1	These	These	B-NP	DT	O	4	NMOD	-1
2	two	two	I-NP	CD	O	4	NMOD	-1
3	transcription	transcription	I-NP	NN	B-protein	4	NMOD	0
4	factors	factor	I-NP	NNS	I-protein	6	SUB	-1
5	also	also	B-ADVP	RB	O	6	VMOD	-1
6	play	play	B-VP	VBP	O	0	ROOT	0
7	an	an	B-NP	DT	O	9	NMOD	-1
8	important	important	I-NP	JJ	O	9	NMOD	0
9	role	role	I-NP	NN	O	6	OBJ	0
10	in	in	B-PP	IN	O	6	VMOD	-1
11	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	10	PMOD	-1
12	,	,	O	,	O	6	P	-1
13	in	in	B-PP	IN	O	6	VMOD	-1
14	extracellular	extracellular	B-NP	JJ	O	16	NMOD	-1
15	matrix	matrix	I-NP	NN	O	16	NMOD	-1
16	composition	composition	I-NP	NN	O	13	PMOD	-1
17	,	,	O	,	O	6	P	-1
18	and	and	O	CC	O	6	VMOD	-1
19	in	in	B-PP	IN	O	6	VMOD	-1
20	cytokine	cytokine	B-NP	NN	B-protein	21	NMOD	-1
21	expression	expression	I-NP	NN	O	19	PMOD	0
22	.	.	O	.	O	6	P	-1

1	By	By	B-PP	IN	O	10	VMOD	-1
2	use	use	B-NP	NN	O	1	PMOD	0
3	of	of	B-PP	IN	O	2	NMOD	-1
4	electric	electric	B-NP	JJ	O	7	NMOD	-1
5	mobility	mobility	I-NP	NN	O	7	NMOD	0
6	shift	shift	I-NP	NN	O	7	NMOD	-1
7	assays	assay	I-NP	NNS	O	3	PMOD	-1
8	,	,	O	,	O	10	P	-1
9	we	we	B-NP	PRP	O	10	SUB	-1
10	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	-1
11	that	that	B-SBAR	IN	O	10	VMOD	-1
12	alpha-MSH	alpha-MSH	B-NP	NN	O	25	SUB	-1
13	(	(	O	(	O	17	DEP	-1
14	10	10	B-NP	CD	O	17	DEP	-1
15	(	(	O	(	O	17	DEP	-1
16	-6	-6	B-NP	CD	O	17	DEP	-1
17	)	)	O	)	O	12	NMOD	-1
18	to	to	B-PP	TO	O	12	NMOD	-1
19	10	10	B-NP	CD	O	23	NMOD	-1
20	(	(	O	(	O	22	DEP	-1
21	-14	-14	B-NP	CD	O	22	DEP	-1
22	)	)	O	)	O	19	NMOD	-1
23	M	M	B-NP	NN	O	18	PMOD	-1
24	)	)	O	)	O	23	NMOD	-1
25	activates	activate	B-VP	VBZ	O	11	SBAR	17	activates
26	AP-1	AP-1	B-NP	NN	B-protein	25	OBJ	-1
27	in	in	B-PP	IN	O	25	VMOD	-1
28	human	human	B-NP	JJ	B-cell_type	30	NMOD	-1
29	dermal	dermal	I-NP	JJ	I-cell_type	30	NMOD	-1
30	fibroblasts	fibroblast	I-NP	NNS	I-cell_type	27	PMOD	-1
31	,	,	O	,	O	25	P	-1
32	whereas	whereas	O	IN	O	25	VMOD	-1
33	coincubation	coincubation	B-NP	NN	O	41	SUB	19	coincubation
34	with	with	B-PP	IN	O	33	NMOD	-1
35	interleukin-1	interleukin-1	B-NP	NN	B-protein	36	NMOD	-1
36	beta	beta	I-NP	NN	I-protein	34	PMOD	-1
37	(	(	O	(	O	40	DEP	-1
38	IL-1	IL-1	B-NP	NN	B-protein	39	NMOD	-1
39	beta	beta	I-NP	NN	I-protein	40	DEP	-1
40	)	)	O	)	O	36	NMOD	-1
41	results	result	B-VP	VBZ	O	32	SBAR	0
42	in	in	B-PP	IN	O	41	VMOD	-1
43	suppression	suppression	B-NP	NN	O	42	PMOD	18	suppression
44	of	of	B-PP	IN	O	43	NMOD	-1
45	its	its	B-NP	PRP$	O	46	NMOD	-1
46	activation	activation	I-NP	NN	O	44	PMOD	0
47	.	.	O	.	O	10	P	-1

1	alpha-MSH	alpha-MSH	B-NP	NN	O	3	SUB	-1
2	also	also	B-ADVP	RB	O	3	VMOD	-1
3	induces	induce	B-VP	VBZ	O	0	ROOT	17	induces
4	activation	activation	B-NP	NN	O	3	OBJ	17	activation
5	of	of	B-PP	IN	O	4	NMOD	-1
6	NF-kappa	NF-kappa	B-NP	NN	B-protein	7	NMOD	-1
7	B	B	I-NP	NN	I-protein	5	PMOD	-1
8	but	but	O	CC	O	3	VMOD	-1
9	does	do	B-VP	VBZ	O	3	VMOD	-1
10	not	not	I-VP	RB	O	9	VMOD	-1
11	modulate	modulate	I-VP	VB	O	9	VC	16	modulate
12	DNA	DNA	B-NP	NN	O	13	NMOD	-1
13	binding	binding	I-NP	NN	O	11	OBJ	15	binding
14	on	on	B-PP	IN	O	13	NMOD	-1
15	costimulation	costimulation	B-NP	NN	O	14	PMOD	17	costimulation
16	with	with	B-PP	IN	O	15	NMOD	-1
17	IL-1	IL-1	B-NP	NN	B-protein	18	NMOD	-1
18	beta	beta	I-NP	NN	I-protein	16	PMOD	-1
19	.	.	O	.	O	3	P	-1

1	Since	Since	B-SBAR	IN	O	36	VMOD	-1
2	AP-1	AP-1	B-NP	NN	B-protein	5	NMOD	-1
3	and	and	O	CC	O	5	NMOD	-1
4	NF-kappa	NF-kappa	B-NP	NN	B-protein	5	NMOD	-1
5	B	B	I-NP	NN	I-protein	6	SUB	-1
6	are	be	B-VP	VBP	O	1	SBAR	-1
7	key	key	B-NP	JJ	O	8	NMOD	-1
8	elements	element	I-NP	NNS	O	6	PRD	-1
9	in	in	B-PP	IN	O	6	VMOD	-1
10	controlling	control	B-VP	VBG	O	9	PMOD	16	controlling
11	interleukin-8	interleukin-8	B-NP	NN	B-protein	15	NMOD	-1
12	(	(	O	(	O	14	DEP	-1
13	IL-8	IL-8	B-NP	NN	B-protein	14	DEP	-1
14	)	)	O	)	O	11	NMOD	-1
15	transcription	transcription	B-NP	NN	O	10	OBJ	10	transcription
16	,	,	O	,	O	36	P	-1
17	human	human	B-NP	JJ	B-cell_type	18	NMOD	-1
18	fibroblasts	fibroblast	I-NP	NNS	I-cell_type	19	SUB	-1
19	were	be	B-VP	VBD	O	36	VMOD	-1
20	treated	treat	I-VP	VBN	O	19	VC	19	treated
21	with	with	B-PP	IN	O	20	VMOD	-1
22	alpha-MSH	alpha-MSH	B-NP	NN	O	25	NMOD	-1
23	and	and	I-NP	CC	O	25	NMOD	-1
24	IL-1	IL-1	I-NP	NN	B-protein	25	NMOD	-1
25	beta	beta	I-NP	NN	I-protein	21	PMOD	-1
26	for	for	B-PP	IN	O	20	VMOD	-1
27	24	24	B-NP	CD	O	28	NMOD	-1
28	hours	hour	I-NP	NNS	O	26	PMOD	-1
29	,	,	O	,	O	36	P	-1
30	and	and	O	CC	O	32	NMOD	-1
31	cytokine	cytokine	B-NP	NN	B-protein	32	NMOD	-1
32	levels	level	I-NP	NNS	O	36	SUB	-1
33	in	in	B-PP	IN	O	32	NMOD	-1
34	the	the	B-NP	DT	O	35	NMOD	-1
35	supernatants	supernatant	I-NP	NNS	O	33	PMOD	-1
36	were	be	B-VP	VBD	O	0	ROOT	-1
37	measured	measure	I-VP	VBN	O	36	VC	-1
38	by	by	B-PP	IN	O	37	VMOD	-1
39	ELISA.	ELISA.	B-NP	NN	O	40	NMOD	-1
40	alpha-MSH	alpha-MSH	I-NP	NN	O	38	PMOD	-1
41	alone	alone	B-ADVP	RB	O	40	NMOD	-1
42	had	have	B-VP	VBD	O	36	VMOD	-1
43	little	little	B-NP	JJ	O	44	NMOD	-1
44	effect	effect	I-NP	NN	O	42	OBJ	0
45	,	,	O	,	O	36	P	-1
46	whereas	whereas	O	IN	O	36	VMOD	-1
47	coincubation	coincubation	B-NP	NN	O	51	SUB	19	coincubation
48	with	with	B-PP	IN	O	47	NMOD	-1
49	IL-1	IL-1	B-NP	NN	B-protein	50	NMOD	-1
50	beta	beta	I-NP	NN	I-protein	48	PMOD	-1
51	led	lead	B-VP	VBD	O	46	SBAR	17	led
52	to	to	B-PP	TO	O	51	VMOD	-1
53	marked	marked	B-NP	JJ	O	54	NMOD	-1
54	downregulation	downregulation	I-NP	NN	O	52	PMOD	18	downregulation
55	of	of	B-PP	IN	O	54	NMOD	-1
56	IL-8	IL-8	B-NP	NN	B-protein	57	NMOD	-1
57	secretion	secretion	I-NP	NN	O	55	PMOD	14	secretion
58	(	(	O	(	O	65	DEP	-1
59	at	at	B-PP	IN	O	64	NMOD	-1
60	most	most	B-NP	JJS	O	59	AMOD	-1
61	288	288	I-NP	CD	O	59	AMOD	-1
62	+/-	+/-	I-NP	SYM	O	59	AMOD	-1
63	152	152	I-NP	CD	O	59	AMOD	-1
64	ng/mL	ng/mL	I-NP	NN	O	65	DEP	-1
65	)	)	O	)	O	54	NMOD	-1
66	when	when	B-ADVP	WRB	O	51	VMOD	-1
67	compared	compare	B-PP	VBN	O	66	SBAR	-1
68	to	to	B-PP	TO	O	67	VMOD	-1
69	treatment	treatment	B-NP	NN	O	68	PMOD	19	treatment
70	with	with	B-PP	IN	O	69	NMOD	-1
71	IL-1	IL-1	B-NP	NN	B-protein	72	NMOD	-1
72	beta	beta	I-NP	NN	I-protein	70	PMOD	-1
73	alone	alone	B-ADVP	RB	O	72	NMOD	-1
74	(	(	O	(	O	79	DEP	-1
75	919	919	B-NP	CD	O	77	AMOD	-1
76	+/-	+/-	I-NP	SYM	O	77	AMOD	-1
77	157	157	I-NP	CD	O	78	NMOD	-1
78	ng/mL	ng/mL	I-NP	NN	O	79	DEP	-1
79	)	)	O	)	O	72	NMOD	-1
80	.	.	O	.	O	36	P	-1

1	Our	Our	B-NP	PRP$	O	2	NMOD	-1
2	results	result	I-NP	NNS	O	3	SUB	0
3	indicate	indicate	B-VP	VBP	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	19	DEP	-1
5	alpha-MSH	alpha-MSH	B-NP	NN	O	6	SUB	-1
6	exerts	exert	B-VP	VBZ	O	4	SBAR	-1
7	modulatory	modulatory	B-NP	JJ	O	8	NMOD	-1
8	effects	effect	I-NP	NNS	O	6	OBJ	16	effects
9	on	on	B-PP	IN	O	6	VMOD	-1
10	the	the	B-NP	DT	O	11	NMOD	-1
11	activation	activation	I-NP	NN	O	9	PMOD	17	activation
12	of	of	B-PP	IN	O	11	NMOD	-1
13	NF-kappa	NF-kappa	B-NP	NN	B-protein	14	NMOD	-1
14	B	B	I-NP	NN	I-protein	16	NMOD	-1
15	and	and	O	CC	O	16	NMOD	-1
16	AP-1	AP-1	B-NP	NN	B-protein	12	PMOD	-1
17	,	,	O	,	O	19	P	-1
18	and	and	O	CC	O	19	DEP	-1
19	that	that	B-SBAR	IN	O	3	VMOD	-1
20	it	it	B-NP	PRP	O	21	SUB	-1
21	can	can	B-VP	MD	O	19	SBAR	-1
22	regulate	regulate	I-VP	VB	O	21	VC	0
23	chemokine	chemokine	B-NP	NN	B-protein	24	NMOD	-1
24	secretion	secretion	I-NP	NN	O	22	OBJ	0
25	in	in	B-PP	IN	O	24	NMOD	-1
26	human	human	B-NP	JJ	B-cell_type	28	NMOD	-1
27	dermal	dermal	I-NP	JJ	I-cell_type	28	NMOD	-1
28	fibroblasts	fibroblast	I-NP	NNS	I-cell_type	25	PMOD	-1
29	.	.	O	.	O	3	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	effects	effect	I-NP	NNS	O	5	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	-1
4	alpha-MSH	alpha-MSH	B-NP	NN	B-protein	3	PMOD	-1
5	may	may	B-VP	MD	O	0	ROOT	-1
6	have	have	I-VP	VB	O	5	VC	-1
7	important	important	B-NP	JJ	O	9	NMOD	0
8	regulatory	regulatory	I-NP	JJ	O	9	NMOD	-1
9	functions	function	I-NP	NNS	O	6	OBJ	0
10	in	in	B-PP	IN	O	6	VMOD	-1
11	extracellular	extracellular	B-NP	JJ	O	13	NMOD	-1
12	matrix	matrix	I-NP	NN	O	13	NMOD	-1
13	composition	composition	I-NP	NN	O	10	PMOD	-1
14	,	,	O	,	O	6	P	-1
15	wound	wound	B-NP	NN	O	16	NMOD	-1
16	healing	healing	I-NP	NN	O	6	VMOD	-1
17	,	,	O	,	O	6	P	-1
18	or	or	O	CC	O	6	VMOD	-1
19	angiogenesis	angiogenesis	B-NP	NN	O	6	VMOD	3	angiogenesis
20	.	.	O	.	O	5	P	-1

